Drug Interactions9 min readUpdated 2025-04-03

    GLP-1 and Prozac (Fluoxetine): Drug Interactions and Safety Guide

    Can you take semaglutide or tirzepatide with Prozac? Complete guide to GLP-1 and fluoxetine interactions, weight effects, safety considerations, and what to discuss with your doctor.

    Key Takeaway

    No direct drug interaction exists between GLP-1 medications and Prozac (fluoxetine). However, delayed gastric emptying from semaglutide or tirzepatide may affect absorption timing. Inform all prescribers about your complete medication list.

    Safety Considerations

    Absorption Effects

    GLP-1 medications slow gastric emptying by 30-50%. This may delay peak absorption of oral Prozac but is unlikely to reduce total absorption. Take Prozac consistently at the same time each day.

    Nausea Management

    Both GLP-1 medications and Prozac can cause nausea, especially when starting. If nausea is severe, discuss timing strategies with your provider -- such as taking Prozac at a different time than your GLP-1 injection.

    Serotonin Considerations

    GLP-1 medications affect gut serotonin signaling. While serotonin syndrome risk is extremely low with this combination, report any symptoms of agitation, rapid heartbeat, or muscle rigidity.

    Weight-Related Dose Adjustments

    Significant weight loss can change medication metabolism. Your Prozac dose may need adjustment as you lose weight. Never adjust doses on your own -- work with your prescriber.

    Potential Benefits of the Combination

    Complementary Effects

    • Both may reduce compulsive eating
    • Prozac is weight-neutral among SSRIs
    • Improved mood may support lifestyle changes

    Monitoring Points

    • Track mood changes during weight loss
    • Report combined nausea to provider
    • Monitor for appetite changes

    Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Never start, stop, or change medications without consulting your healthcare provider. Drug interactions depend on individual factors.

    Frequently Asked Questions

    Can I take semaglutide or tirzepatide with Prozac?

    Generally, yes. There is no known direct pharmacological interaction between GLP-1 medications and fluoxetine (Prozac). However, GLP-1 medications slow gastric emptying, which may affect how quickly Prozac is absorbed. Always inform both prescribers about all medications you take.

    Will Prozac affect my weight loss on GLP-1?

    Fluoxetine is considered weight-neutral to mildly weight-loss-promoting among SSRIs, so it is unlikely to significantly counteract GLP-1 weight loss. Some patients find the combination helpful as both can reduce compulsive eating behaviors.

    Can GLP-1 medications affect my mood if I take Prozac?

    Some GLP-1 users report mood improvements through reduced food anxiety and improved self-image. However, rapid dietary changes can affect serotonin levels. Monitor your mood carefully when starting or adjusting either medication.

    Should I adjust my Prozac dose when starting GLP-1 treatment?

    Do not adjust your Prozac dose without consulting your prescriber. As you lose weight, medication metabolism may change. Your doctor may need to adjust your antidepressant dose over time based on your response.

    Get GLP-1 Treatment with Full Medication Review

    Compounded semaglutide from $99/mo or tirzepatide from $125/mo. Providers review your full medication list.

    View Treatment Options

    Sources & References

    1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
    2. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
    3. Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
    4. FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).

    What does the current clinical evidence support for GLP-1-based weight management?

    GLP-1 receptor agonists (semaglutide, tirzepatide) have Phase 3 RCT evidence for chronic weight management in adults with BMI ≥30 or BMI ≥27 with a weight-related comorbidity. Trimi offers compounded preparations of the same active ingredients at $99/month (semaglutide) and $125/month (tirzepatide) on the annual plan, prepared per individual prescription by 503A community sterile compounding pharmacies and reviewed by a US-licensed clinician through Beluga Health's 50-state physician network. Compounded preparations are not themselves FDA-approved as drugs; the active ingredients are FDA-approved in the corresponding brand finished products. Eligibility is determined by a licensed clinician.

    Phase 3 RCT evidence base: STEP 1 (NEJM 2021), SURMOUNT-1 (NEJM 2022), SELECT (NEJM 2023), FLOW (NEJM 2024)
    Trimi pricing: $99/month semaglutide / $125/month tirzepatide on annual plan
    Clinical review: Dr. Asad Niazi, MD MPH via Beluga Health 50-state network

    Key Takeaways

    • Compounded semaglutide and compounded tirzepatide are prepared per individual prescription by 503A community sterile compounding pharmacies (VialsRx — Texas State Board pharmacy license #35264 — and GreenwichRx). The active ingredients (semaglutide, tirzepatide) are FDA-approved in the corresponding brand finished products (Wegovy / Ozempic and Zepbound / Mounjaro respectively). Compounded preparations are not themselves FDA-approved as drugs.
    • Eligibility for GLP-1 treatment is determined by a licensed clinician: BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease). Contraindications include personal/family history of medullary thyroid carcinoma, MEN 2 syndrome, pancreatitis, severe gastrointestinal disease, severe renal impairment, pregnancy, and breastfeeding.
    • Common GLP-1 receptor agonist adverse effects include nausea, vomiting, diarrhea, constipation, and gallbladder events. Most are mild-to-moderate and concentrated during dose escalation. Severe gastrointestinal symptoms causing dehydration can increase acute kidney injury risk and should be reported to the prescribing clinician.
    • Trimi's clinical review is coordinated by Dr. Asad Niazi, MD MPH through Beluga Health's 50-state physician network. Trimi pricing: $99/month for compounded semaglutide and $125/month for compounded tirzepatide on the annual plan; flat across all prescribed doses within whichever plan, with no enrollment / consultation / shipping fees.
    • This is general information based on the cited sources, not medical advice. Treatment decisions require evaluation by a licensed clinician familiar with your individual medical history.

    Medically Reviewed

    TMRT

    Trimi Medical Review Team

    Clinical review workflow for GLP-1 safety, dosing, and access content

    Team-based medical review process documented in Trimi's Medical Review Policy

    Last reviewed: November 21, 2025

    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Medically reviewed by Trimi Medical Review Team, Clinical review workflow for GLP-1 safety, dosing, and access content

    What real Trimi patients say

    Verbatim quotes from Trimi's Facebook and Reddit community reviews. First name and last initial preserved per editorial policy.

    Amazing company and care team support! Fast response time, no hidden fees and they actually care enough to work with you and your needs on your weight loss journey. Down 12.5 pounds in 2 months!

    Outcome: Down 12.5 lbs in 2 months

    Sarah MillerFacebook
    Arrived within 24 hours. Easy to use. Comes with everything. The year is so worth it.

    Outcome: Same-day delivery experience

    Veronica LarimoreFacebook

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Scientific References

    1. Garvey WT, Mechanick JI, Brett EM, et al. (2024). American Association of Clinical Endocrinology / American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocrine Practice.Read StudyDOI: 10.4158/EP161365.GL
    2. American Heart Association (2021). Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation.Read StudyDOI: 10.1161/CIR.0000000000000973
    3. Apovian CM, Aronne LJ, Bessesen DH, et al. (2015). Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism.Read StudyDOI: 10.1210/jc.2014-3415

    Was this article helpful?

    Keep Reading

    Can you safely take GLP-1 medications with Effexor? Guide to semaglutide/tirzepatide and venlafaxine interactions, weight gain concerns, and managing both medications together.

    Can you take GLP-1 medications with Seroquel? Guide to semaglutide/tirzepatide and quetiapine interactions, managing severe antipsychotic weight gain, and safe combination use.

    Can you safely take GLP-1 medications with Cymbalta? Guide to semaglutide/tirzepatide and duloxetine interactions, weight management, and combining treatments.

    Can you take GLP-1 medications with Concerta? Guide to semaglutide/tirzepatide and methylphenidate interactions, combined appetite effects, and managing both safely.

    Start your GLP-1 journey — from $99/mo

    Get Started